Expert Opinion on Drug Safety, Volume 19, Issue 4 (2020)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Safety, Volume 19, Issue 4 (2020)

See all volumes and issues
Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Volume 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Dermatology

Foreword

Introduction
Medications in dermatology are safer and more efficient than they used to be
Britney N. Wilson, Esther A. Balogh & Steven R. Feldman
Pages: 359-360
Published online: 21 Feb 2020
CitationforMedications in dermatology are safer and more efficient than they used to be | Full Text | References | PDF (249.4 KB) | EPUB
  • 895 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Editorial

Editorial
How can we manage the safety concerns associated with the increase in biologics for psoriasis?
Annika Silfvast-Kaiser & Martin Alan Menter
Pages: 361-364
Published online: 31 Jan 2020
First Page PreviewforHow can we manage the safety concerns associated with the increase in biologics for psoriasis? | Full Text | References | PDF (586.5 KB) | EPUB
  • 1798 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Drug Safety Evaluation

Article
The safety of brodalumab for the treatment of psoriasis
Helena Iznardo & Lluís Puig
Pages: 365-372
Published online: 21 Feb 2020
AbstractforThe safety of brodalumab for the treatment of psoriasis | Full Text | References | PDF (753.5 KB) | EPUB
  • 407 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
A safety evaluation of dimethyl fumarate in moderate-to-severe psoriasis
Radomir Reszke & Jacek C. Szepietowski
Pages: 373-380
Published online: 11 Mar 2020
AbstractforA safety evaluation of dimethyl fumarate in moderate-to-severe psoriasis | Full Text | References | PDF (640.7 KB) | EPUB
  • 279 Views
  • 19 CrossRef citations
  • 0Altmetric
Article
Long-term safety of adalimumab for patients with moderate-to-severe hidradenitis suppurativa
Vassiliki Tzanetakou, Dimitra Stergianou & Evangelos J. Giamarellos-Bourboulis
Pages: 381-393
Published online: 28 Feb 2020
AbstractforLong-term safety of adalimumab for patients with moderate-to-severe hidradenitis suppurativa | Full Text | References | PDF (953.2 KB) | EPUB
  • 473 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
A drug safety evaluation of risankizumab for psoriasis
Yi-Wei Huang & Tsen-Fang Tsai
Pages: 395-402
Published online: 05 Mar 2020
AbstractforA drug safety evaluation of risankizumab for psoriasis | Full Text | References | PDF (750.5 KB) | EPUB
  • 1113 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
An update on the safety of apremilast for the treatment of plaque psoriasis
Eran Shavit & Neil H. Shear
Pages: 403-408
Published online: 21 Mar 2020
AbstractforAn update on the safety of apremilast for the treatment of plaque psoriasis | Full Text | References | PDF (608.5 KB) | EPUB
  • 292 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
An update on the safety of nivolumab for the treatment of advanced melanoma
Anna M Czarnecka & Piotr Rutkowski
Pages: 409-421
Published online: 29 Apr 2020
AbstractforAn update on the safety of nivolumab for the treatment of advanced melanoma | Full Text | References | PDF (1 MB) | EPUB
  • 1427 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Safety of calcipotriene and betamethasone dipropionate foam for the treatment of psoriasis
Victoria Amat-Samaranch & Lluís Puig
Pages: 423-432
Published online: 13 Apr 2020
AbstractforSafety of calcipotriene and betamethasone dipropionate foam for the treatment of psoriasis | Full Text | References | PDF (875.9 KB) | EPUB
  • 265 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Adalimumab in children and adolescents with severe plaque psoriasis: a safety evaluation
A. Zangrilli, M. Bavetta & L. Bianchi
Pages: 433-438
Published online: 26 Apr 2020
AbstractforAdalimumab in children and adolescents with severe plaque psoriasis: a safety evaluation | Full Text | References | PDF (506.5 KB) | EPUB
  • 259 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Safety update of etanercept treatment for moderate to severe plaque psoriasis
Anna Campanati, Federico Diotallevi, Emanuela Martina, Matteo Paolinelli, Giulia Radi & Annamaria Offidani
Pages: 439-448
Published online: 19 Mar 2020
AbstractforSafety update of etanercept treatment for moderate to severe plaque psoriasis | Full Text | References | PDF (792.1 KB) | EPUB
  • 388 Views
  • 12 CrossRef citations
  • 0Altmetric

Review

Review
How is safety of dermatology drugs assessed: trials, registries, and spontaneous reporting
Leila Asfour, Zenas Z.N. Yiu & Richard B. Warren
Pages: 449-457
Published online: 31 Mar 2020
AbstractforHow is safety of dermatology drugs assessed: trials, registries, and spontaneous reporting | Full Text | References | PDF (920.7 KB) | EPUB
  • 286 Views
  • 5 CrossRef citations
  • 0Altmetric
Review
Are biosimilars approved for use in psoriasis safe enough to replace leading biologic therapies? A review
Kelly A. Reynolds, Deeti J Pithadia, Erica B Lee, George Han & Jashin J Wu
Pages: 459-466
Published online: 09 Mar 2020
AbstractforAre biosimilars approved for use in psoriasis safe enough to replace leading biologic therapies? A review | Full Text | References | PDF (741.1 KB) | EPUB
  • 271 Views
  • 4 CrossRef citations
  • 0Altmetric
Review
Safety considerations when using drugs to treat pruritus
Kayla Fourzali & Gil Yosipovitch
Pages: 467-477
Published online: 17 Feb 2020
AbstractforSafety considerations when using drugs to treat pruritus | Full Text | References | PDF (944.5 KB) | EPUB
  • 281 Views
  • 5 CrossRef citations
  • 0Altmetric
Review
Neurologic complications of immune checkpoint inhibitors
Alexandra M Haugh, John C Probasco & Douglas B Johnson
Pages: 479-488
Published online: 11 Mar 2020
AbstractforNeurologic complications of immune checkpoint inhibitors | Full Text | References | PDF (792.3 KB) | EPUB
  • 1856 Views
  • 65 CrossRef citations
  • 0Altmetric
Review
Safety considerations with combination therapies for psoriasis
Mio Nakamura & John Koo
Pages: 489-498
Published online: 03 Feb 2020
AbstractforSafety considerations with combination therapies for psoriasis | Full Text | References | PDF (878.2 KB) | EPUB
  • 415 Views
  • 12 CrossRef citations
  • 0Altmetric
Review
Safety of the current drug treatments for vitiligo
Torello Lotti, Komal Agarwal, Indrashis Podder, Francesca Satolli, Martin Kassir, Robert A Schwartz, Uwe Wollina, Stephan Grabbe, Alexander A Navarini, Simon M Mueller & Mohamad Goldust
Pages: 499-511
Published online: 16 Mar 2020
AbstractforSafety of the current drug treatments for vitiligo | Full Text | References | PDF (1.1 MB) | EPUB
  • 483 Views
  • 10 CrossRef citations
  • 0Altmetric
Review
Adverse events related to topical drug treatments for acne vulgaris
Agnieszka Otlewska, Wojciech Baran & Aleksandra Batycka-Baran
Pages: 513-521
Published online: 29 Apr 2020
AbstractforAdverse events related to topical drug treatments for acne vulgaris | Full Text | References | PDF (713 KB) | EPUB
  • 483 Views
  • 2 CrossRef citations
  • 0Altmetric
Review
Safety concerns with current treatments for psoriasis in the elderly
Roberta Di Caprio, Giuseppina Caiazzo, Sara Cacciapuoti, Gabriella Fabbrocini, Emanuele Scala & Anna Balato
Pages: 523-531
Published online: 14 Feb 2020
AbstractforSafety concerns with current treatments for psoriasis in the elderly | Full Text | References | PDF (730.7 KB) | EPUB
  • 405 Views
  • 17 CrossRef citations
  • 0Altmetric

Explore articles